Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and ...

These five ASX 200 stocks are highly rated by brokers. Let's see what they are recommending as buys after the market ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...

AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.

Cardinal is using its own cyclotron installations to produce Gozellix for distribution across a range of US locations.

Cardinal Health (NYSE:CAH) has been selected as a distributor for Telix Pharmaceuticals' Gozellix®, an important development ...

Find insight on Microbix Biosystems, Lonza, China’s healthcare sector and more in the latest Market Talks covering the Health Care sector.

To support the rollout, Cardinal Health has deployed Telix’s ARTMS QUANTM Irradiation System® (QIS®) cyclotron technology, enabling standardized, high-efficiency and cost-effective production of ...

To support the rollout, Cardinal Health has deployed Telix's ARTMS QUANTM Irradiation System® (QIS®) cyclotron technology, enabling standardized, high-efficiency and cost-effective production of ...

This is for production and delivery of its US Food and Drug Administration (FDA)-approved prostate cancer imaging agents, Illuccix and Gozellix. “Due to the ‘just-in-time’ nature of ...